Published in Women's Health Law Weekly, January 25th, 2009
"This study sought to compare the efficacy and safety of different TRALI risk-reduction strategies at a hospital-based donor center. Samples from 1053 donors who answered questions regarding pregnancy and transfusion history were tested for HLA Class I and II antibodies using a flow cytometry-based screening assay. Donor history was compared with the presence of HLA alloantibodies. These data were used to model several TRALI risk-reduction...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly